Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,153.7
-28.7 (-0.90%)

 

  • STI Straits Times Index
    3,153.7
    -28.7 (-0.90%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.0
    -9.9 (-0.62%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,979.3
    -616.3 (-2.16%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,441.8
    13.9 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,608.6
    -909.8 (-3.08%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,922.7
    -53.1 (-0.89%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,531.0M
  • Value: 1,093.1M
  • Rise: 104
  • Fall: 219
  • Unch: 451

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.009-0.001
Sembcorp Marine0.193-0.003
Renaissance United0.004-
AP Strategic0.002-
Golden Agri-Res0.265+0.010
Jiutian Chemical0.096-0.002
YZJ Shipbldg SGD1.480-0.040
Beverly JCG0.001-
Oceanus^0.036-
Genting Sing0.820-0.020

World Indices

World Indices
Name Last Change
Nasdaq 13,401.9 -350.4
HSI 27,990.0 -605.7
HSCEI 10,416.4 -234.7
Jakarta 5,924.3 -51.5
Nikkei 225 28,608.6 -909.8
SSE Comp 3,441.8 +13.8
Shanghai A 3,607.5 +14.5
Shanghai B 250.1 +0.7
KOSPI 3,209.4 -39.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ARCUS BIOSCIENCES INC ARCUS BIOSCIENCES
Updated on 10 May 2021 (End of trading day)
Last (USD): 28.860 Change: -1.590 High: 30.460 Remarks: -
Change (%): -5.22 Low: 28.620
Open 30.070 Yesterday's Close 30.45
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 567,923 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.73049 Trailing EPS (USD) e -2.36224 NAV (USD) b 9.3644
PE a - Trailing PE f - Price / NAV b 3.0819
Dividend (USD) d - Cash In Hand (USD) g 12.4651 Issued & Paid-up Shares c 70,995,900
Dividend Yield (%) d - Price / Cash In Hand g 2.315 Treasury Shares h -
Market Cap (M) 2,048.942 Enterprise Value (M) 1,164.030
Piotroski F Score 3 Exchange Code RCUS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.38 Free Float (%) 59.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Mar 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ARCUS BIOSCIENCES INC NYSE 2,048.942 - - 3.0819 -
Industry Biotechnology NYSE 1,314.878 55.281 158.853 9.0640 -
Local Peer NUVATION BIO INC NYSE 2,400.680 - - 16.8809 -
Local Peer MYOVANT SCIENCES LTD NYSE 1,661.487 - - -6.1387 -
Local Peer SQZ BIOTECHNOLOGIES CO NYSE 322.591 - - 2.5361 -
Local Peer ENZO BIOCHEM INC NYSE 140.828 - - 2.2791 -
Global Peer AMGEN INC NASDAQ 145,143.831 19.981 20.486 15.5501 2.550
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 125,321.843 39.958 32.929 11.8594 1.065
Global Peer GILEAD SCIENCES INC NASDAQ 84,632.066 688.080 281.129 4.4621 4.031
Global Peer MODERNA INC NASDAQ 63,448.539 - - - -
Global Peer ILLUMINA INC NASDAQ 55,547.160 84.676 88.170 11.2855 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,112.571 20.324 19.954 6.1371 -
Global Peer WUXI BIO HKEx 416,678.729 219.558 219.560 17.0896 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 53,521.298 15.234 18.528 - -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 48,871.774 2,820.995 2,820.828 29.1159 -
Other Global Peers BIOGEN INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), GENSCRIPT BIO (HKEx), JOINN (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), Lonza (SGX), BEAM THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), KINTOR PHARMA-B (HKEx), NANOSTRING TECHNOLOGIES INC (NASDAQ), VERACYTE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INSTIL BIO INC (NASDAQ), SEER INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), XENCOR INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), JACOBIO-B (HKEx), PRELUDE THERAPEUTICS INC (NASDAQ), ALPHAMAB-B (HKEx), MACROGENICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), OCUGEN INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CYTOKINETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VIVA BIOTECH (HKEx), IMMUNOVANT INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOATLA INC (NASDAQ), HAOHAI BIOTEC (HKEx), JW THERAP-B (HKEx), ALLOVIR INC (NASDAQ), REGENXBIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), FRONTAGE (HKEx), ALECTOR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MIMEDX GROUP INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), CORTEXYME INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), JHBP-B (HKEx), ENANTA PHARMACEUTICALS INC (NASDAQ), IMUGENE LIMITED (ASX), RADIUS HEALTH INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), NKARTA INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VAXART INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), EPIZYME INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MERUS B V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CHEMOCENTRYX INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), AGENUS INC (NASDAQ), ARDELYX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), COMPUGEN (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INHIBRX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), ASPIRA WOMENS HEALTH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), VERASTEM INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKOUOS INC (NASDAQ), SESEN BIO INC (NASDAQ), ADICET BIO INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), ASCLETIS-B (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), FORTE BIOSCIENCES INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), GERON CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ONCORUS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), AVROBIO INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), LEE'S PHARM (HKEx), CUE BIOPHARMA INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOME INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CHIASMA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NANOVIRICIDES INC (NYSE American), GALECTIN THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD (ASX), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOVIE INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CEL-SCI CORP (NYSE American), MEDICENNA THERAPEUTICS CORP (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), BIONOMICS LTD (ASX), SAVARA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), IMV INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), INFLARX N V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOMX INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IBIO INC (NYSE American), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ORGENESIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ANIXA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), OTONOMY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), CIDARA THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), LEAF RESOURCES LTD (ASX), MERRIMACK PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), LUMOS PHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CELLECTAR BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), MONOPAR THERAPEUTICS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), NEUROBO PHARMACEUTICALS INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), VACCINEX INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SOLIGENIX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CT ENTERPRISE (HKEx), CYCLO THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ARCA BIOPHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), PALISADE BIO INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ADITX THERAPEUTICS INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GEOVAX LABS INC (NASDAQ), MEMPHASYS LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), HISTOGEN INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BENITEC BIOPHARMA INC (NASDAQ), Suntar Eco-City (SGX), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), RHINOMED LIMITED (ASX), BIOTRON (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BIOSINO BIO-TEC (HKEx), ADALTA LTD (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CRYOSITE (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --3.840
-11.74 %
10 Days --5.880
-16.93 %
20 Days --3.590
-11.06 %
Medium Term Return 3 Months --11.100
-27.78 %
6 Months -+6.210
+27.42 %
1 Year --0.430
-1.47 %
Long Term Return 2 Years -+18.890
+189.47 %
3 Years -+12.730
+78.92 %
Annualised Return Annualised --
+21.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 16.690 - 42.360 Change From 1 Year Low +12.170 % Change From 1 Year Low (%) +72.92
Change From 1 Year High -13.500 % Change From 1 Year High (%) -31.87
2 Years Range 6.300 - 42.360 Change From 2 Years Low +22.560 % Change From 2 Years Low (%) +358.10
Change From 2 Years High -13.500 % Change From 2 Years High (%) -31.87
5 Years Range 6.300 - 42.360 Change From 5 Years Low +22.560 % Change From 5 Years Low (%) +358.10
Change From 5 Years High -13.500 % Change From 5 Years High (%) -31.87
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
10 May 2021 30.070 30.460 28.620 28.860 567,923 -
07 May 2021 30.580 31.525 30.270 30.450 560,347 -
06 May 2021 30.280 30.790 28.880 30.130 1,160,135 -
05 May 2021 32.570 33.390 30.850 30.940 240,563 -
04 May 2021 33.980 35.120 32.630 32.700 659,656 -
03 May 2021 34.500 34.970 33.930 34.100 212,863 -
30 Apr 2021 32.750 33.930 32.610 33.750 316,678 -
29 Apr 2021 34.790 34.790 33.220 33.420 235,840 -
28 Apr 2021 34.170 34.890 33.880 34.500 423,290 -
27 Apr 2021 36.380 36.440 33.680 34.740 583,464 -
26 Apr 2021 35.880 36.110 35.170 35.680 621,063 -
23 Apr 2021 35.000 36.200 34.630 35.770 552,827 -
22 Apr 2021 33.870 34.950 32.810 34.700 408,857 -
21 Apr 2021 31.820 33.990 31.440 33.950 429,699 -
20 Apr 2021 31.620 32.350 31.240 31.950 672,354 -
19 Apr 2021 32.680 33.345 31.840 32.060 301,125 -
16 Apr 2021 34.850 35.445 32.850 33.130 378,779 -
15 Apr 2021 33.590 35.500 33.330 34.990 596,211 -
14 Apr 2021 32.610 33.870 32.360 33.210 506,143 -
13 Apr 2021 30.230 32.630 30.230 32.450 559,105 -
12 Apr 2021 31.290 31.340 29.180 30.490 554,017 -
09 Apr 2021 31.180 32.035 30.680 31.300 316,144 -
Summary
Current 2 Weeks
(27 Apr 2021 to 10 May 2021)
36.380 36.440 28.620 28.860 4,960,759 -
Previous 2 Weeks
(13 Apr 2021 to 26 Apr 2021)
30.230 36.440 28.620 35.680 5,026,163 -
4 Weeks from
(15 Mar 2021 to 12 Apr 2021)
36.200 36.950 28.620 30.490 10,500,724 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.